FGF23 and hypophosphatemia: Case reports of cutaneous skeletal hypophosphatemia syndrome (a rare genetic disorder characterized by dysplastic skeletal lesions, congenital skin nevi and FGF-23-mediated hypophosphatemia) that showed a decrease in clinical symptoms and FGF-23 levels after removal of skin lesions provide further support for this premise [41, 44–46].